pembrolizumab (keytruda) Report issue

Biologics mAb Orphan Drug FDA Approved FDA First in Class Accelerated Approval FDA Priority Review FDA

Back

Chemistry

Mol. Mass

Missing data

ALogP

Missing data

Rule of 5

Missing data

Rule of 3

Missing data
Details

Sources

CHEMBL2364654   ChEMBL

CHEMBL3137343   ChEMBL
pembrolizumab

DPT0O3T46P   NCATS
pembrolizumab *

Pembrolizumab   Wikipedia

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue